Driving CAR-T therapy safety and sustainability for the road ahead
Q&A with Abby McDonald, PhD, Solutions Development Supervisor
Subscribe
Get updates from the Cell Lines Blog delivered to your inbox.
An opportunity to impact the future of medicine
As told by Leah, Be The Match BioTherapies® allogeneic donor
The benefits of a Quality System Audit Program
Accelerate patient access to cell and gene therapies
Standardization in cell therapy industry is a race against time
Accellerate Summit highlights needs and challenges in standardization
The challenge of multiple audits and redundant training
A case study from UCLA Health
Developing and managing a strong collection center network
On-demand webinar available
Industry stakeholders propose unified CAR T toxicity grading scale
CIBMTR Cellular Therapy Registry recommended to meet outcomes data reporting requirements
‘There is no room for error’ in cell and gene therapy logistics
Delivering life-saving therapies on time, every time